• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种更有效的 COVID-19 大流行管理的聚合 RT-PCR 检测策略。

A pooled RT-PCR testing strategy for more efficient COVID-19 pandemic management.

机构信息

Istanbul Medipol University, Istanbul, Turkey.

Istanbul Medipol University, Istanbul, Turkey.

出版信息

Int J Infect Dis. 2022 Mar;116:1-6. doi: 10.1016/j.ijid.2021.12.328. Epub 2021 Dec 15.

DOI:10.1016/j.ijid.2021.12.328
PMID:34922006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8673736/
Abstract

OBJECTIVES

Reverse transcription polymerase chain reaction (RT-PCR) testing is indispensable in management of the coronavirus disease 2019 (COVID-19) pandemic. However, with the emergence of new variants of severe acute respiratory syndrome coronavirus-2, the cause of COVID-19, the screening capacity of RT-PCR testing is overburdened, and new strategies and capabilities need to be established. One option is pooled RT-PCR testing.

DESIGN

This study used various mixtures of COVID-19 samples known to be negative and positive, and investigated the impact of pool size and mixture level on final cycle threshold (Ct) values. More specifically, 5, 10 and 20 negative samples were combined with one, two or three low Ct or high Ct positive samples.

RESULTS

Average baseline Ct and numbers of high and low Ct samples in the pool were found to be the main drivers of the final Ct value, making detectability easier. Pool size was not significantly associated with final Ct, but was suggestive.

CONCLUSIONS

A pooled RT-PCR testing strategy does not reduce the sensitivity of RT-PCR, and thus provides a practical way to expand RT-PCR screening capacity in pandemic management. The pool size was not found to be significant, so it is recommended that a pool size of 20 would be a practical number to reduce the time taken to obtain the results and the cost of RT-PCR testing.

摘要

目的

逆转录聚合酶链反应(RT-PCR)检测对于 2019 年冠状病毒病(COVID-19)大流行的管理是不可或缺的。然而,随着严重急性呼吸系统综合征冠状病毒 2(COVID-19 的致病原)新变体的出现,RT-PCR 检测的筛查能力不堪重负,需要建立新的策略和能力。一种选择是混合 RT-PCR 检测。

设计

本研究使用了各种已知为阴性和阳性的 COVID-19 样本混合物,研究了池大小和混合物水平对最终循环阈值(Ct)值的影响。更具体地说,将 5、10 和 20 个阴性样本与一个、两个或三个低 Ct 或高 Ct 阳性样本混合。

结果

发现平均基线 Ct 和池中的高 Ct 和低 Ct 样本数量是最终 Ct 值的主要驱动因素,使检测变得更容易。池大小与最终 Ct 无显著相关性,但具有提示意义。

结论

混合 RT-PCR 检测策略不会降低 RT-PCR 的敏感性,因此为在大流行管理中扩大 RT-PCR 筛查能力提供了一种实用方法。池大小并不显著,因此建议池大小为 20 是一种实用的方法,可以减少获得结果的时间和 RT-PCR 检测的成本。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1491/8673736/d3979ce4eff2/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1491/8673736/814dc8ab5add/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1491/8673736/f1c8222abed8/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1491/8673736/024f0ad8b98f/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1491/8673736/d3979ce4eff2/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1491/8673736/814dc8ab5add/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1491/8673736/f1c8222abed8/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1491/8673736/024f0ad8b98f/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1491/8673736/d3979ce4eff2/gr4_lrg.jpg

相似文献

1
A pooled RT-PCR testing strategy for more efficient COVID-19 pandemic management.一种更有效的 COVID-19 大流行管理的聚合 RT-PCR 检测策略。
Int J Infect Dis. 2022 Mar;116:1-6. doi: 10.1016/j.ijid.2021.12.328. Epub 2021 Dec 15.
2
Pooled-Testing for SARS-CoV-2 Reverse Transcription Polymerase Chain Reaction (RT-PCR) in asymptomatic healthcare workers in EL-Raghy isolation COVID-19 hospital, Assiut University.在埃勒-拉吉 COVID-19 医院,对无症状的医护人员进行 SARS-CoV-2 逆转录聚合酶链反应(RT-PCR)的混合检测,该医院隶属于艾斯尤特大学。
Egypt J Immunol. 2022 Apr;29(2):68-75.
3
[Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples].[用于呼吸道样本中检测严重急性呼吸综合征冠状病毒2的快速抗原检测试剂盒与聚合酶链反应的评估]
Mikrobiyol Bul. 2022 Apr;56(2):263-273. doi: 10.5578/mb.20229806.
4
Comparison of RT-PCR cycle threshold values between individual and pooled SARS-CoV-2 infected nasopharyngeal swab specimens.个体与混合的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的鼻咽拭子标本之间逆转录聚合酶链反应(RT-PCR)循环阈值的比较。
Narra J. 2024 Aug;4(2):e765. doi: 10.52225/narra.v4i2.765. Epub 2024 Jul 19.
5
Quantitative analysis of RT-PCR test results for SARS-CoV-2 diagnostics across Poland during COVID-19 pandemic: Comparison between early stage and major pandemic waves in 2020 and 2021 with reference to SARS-CoV-2 variants.定量分析 COVID-19 大流行期间波兰各地 SARS-CoV-2 诊断的 RT-PCR 检测结果:2020 年和 2021 年大流行早期阶段与主要流行波之间的比较,并参考了 SARS-CoV-2 变体。
Adv Med Sci. 2022 Sep;67(2):386-392. doi: 10.1016/j.advms.2022.09.002. Epub 2022 Sep 13.
6
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
7
Evaluation of conventional and point-of-care real-time RT-PCR tests for the detection of SARS-CoV-2 through a pooled testing strategy.通过集中检测策略评估常规和即时 RT-PCR 检测 SARS-CoV-2 的效果。
J Clin Lab Anal. 2022 Jun;36(6):e24491. doi: 10.1002/jcla.24491. Epub 2022 May 9.
8
Impact of Pool Testing in Detection of Asymptomatic Patients with COVID-19.池化检测对无症状 COVID-19 患者检测的影响。
Lab Med. 2021 Jan 4;52(1):e15-e16. doi: 10.1093/labmed/lmaa094.
9
Intricacies in characterizing positivity in pooled sample testing for SARS-CoV-2.在汇集样本检测 SARS-CoV-2 时,对阳性结果进行特征描述的复杂性。
J Med Virol. 2021 May;93(5):2799-2804. doi: 10.1002/jmv.26618. Epub 2021 Feb 23.
10
Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction Testing.在接受严重急性呼吸系统综合征冠状病毒 2 型血清学和逆转录聚合酶链反应检测的患者中,流行病学、免疫学和病毒特征。
J Infect Dis. 2022 Jan 18;225(2):229-237. doi: 10.1093/infdis/jiab349.

引用本文的文献

1
Comparison of RT-PCR cycle threshold values between individual and pooled SARS-CoV-2 infected nasopharyngeal swab specimens.个体与混合的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的鼻咽拭子标本之间逆转录聚合酶链反应(RT-PCR)循环阈值的比较。
Narra J. 2024 Aug;4(2):e765. doi: 10.52225/narra.v4i2.765. Epub 2024 Jul 19.
2
Development of a simple and highly sensitive virion concentration method to detect SARS-CoV-2 in saliva.开发一种简单且高度灵敏的病毒粒子浓缩方法以检测唾液中的新型冠状病毒 2 型。
Heliyon. 2024 Jun 15;10(12):e33168. doi: 10.1016/j.heliyon.2024.e33168. eCollection 2024 Jun 30.
3
Severe acute respiratory syndrome coronavirus 2 detection by real time polymerase chain reaction using pooling strategy of nasal samples.

本文引用的文献

1
Evaluation of seven commercial RT-PCR kits for COVID-19 testing in pooled clinical specimens.评价七种用于混合临床标本 COVID-19 检测的商业 RT-PCR 试剂盒。
J Med Virol. 2021 Apr;93(4):2281-2286. doi: 10.1002/jmv.26691. Epub 2020 Dec 17.
2
Pooled testing for COVID-19 diagnosis by real-time RT-PCR: A multi-site comparative evaluation of 5- & 10-sample pooling.实时 RT-PCR 检测 COVID-19 的混合检测:5 份和 10 份混合样本的多中心比较评估。
Indian J Med Res. 2020;152(1 & 2):88-94. doi: 10.4103/ijmr.IJMR_2304_20.
3
Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection.
使用鼻拭子样本混合策略通过实时聚合酶链反应检测严重急性呼吸综合征冠状病毒2
Front Microbiol. 2022 Jul 22;13:957957. doi: 10.3389/fmicb.2022.957957. eCollection 2022.
大规模实施 RNA 提取和 RT-PCR 池检测 SARS-CoV-2。
Clin Microbiol Infect. 2020 Sep;26(9):1248-1253. doi: 10.1016/j.cmi.2020.06.009. Epub 2020 Jun 23.
4
Covid-19: testing times.新冠疫情:考验时刻。
BMJ. 2020 Apr 8;369:m1403. doi: 10.1136/bmj.m1403.
5
Laboratory Diagnosis of COVID-19: Current Issues and Challenges.新型冠状病毒肺炎的实验室诊断:当前的问题和挑战。
J Clin Microbiol. 2020 May 26;58(6). doi: 10.1128/JCM.00512-20.
6
Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19).新型冠状病毒疾病 2019(COVID-19)实验室诊断中的潜在分析前和分析弱点。
Clin Chem Lab Med. 2020 Jun 25;58(7):1070-1076. doi: 10.1515/cclm-2020-0285.
7
Coronavirus disease 2019: What we know?新型冠状病毒肺炎:我们知道什么?
J Med Virol. 2020 Jul;92(7):719-725. doi: 10.1002/jmv.25766. Epub 2020 Mar 28.
8
Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated and with Clinical Specimens.新型高灵敏度和特异性 COVID-19-RdRp/Hel 实时荧光 RT-PCR 检测方法在临床标本中的验证及对 COVID-19 的分子诊断改良
J Clin Microbiol. 2020 Apr 23;58(5). doi: 10.1128/JCM.00310-20.
9
Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management.新型冠状病毒病 2019(COVID-19):胸部 CT 在诊断和管理中的作用。
AJR Am J Roentgenol. 2020 Jun;214(6):1280-1286. doi: 10.2214/AJR.20.22954. Epub 2020 Mar 4.